[Efficacy and safety of adalimumab in Crohn's disease]

Meriem, Serghini; Wafa, Haddad; Hanene, Jeddi; Sami, Karoui; Nadia Ben, Mustapha; Lamia, Kallel; Monia, Fekih; Samira, Matri; Jalel, Boubaker; Azza, Filali

Meriem, Serghini; Wafa, Haddad; Hanene, Jeddi; Sami, Karoui; Nadia Ben, Mustapha; Lamia, Kallel; Monia, Fekih; Samira, Matri; Jalel, Boubaker; Azza, Filali.

Tunisie Medicale [La]. 2012; 90 (2): 101-107

in Fr | IMEMR | ID: emr-178399

Responsible library: EMRO

Subject(s)

Humans; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Humanized/pharmacology; Tumor Necrosis Factor-alpha

Search on Google

Add to My VHL

XML

Index: IMEMR Main subject: Tumor Necrosis Factor-alpha / Antibodies, Monoclonal, Humanized Limits: Humans Language: Fr Journal: Tunisie Med. Year: 2012

Search on Google

Add to My VHL

XML

Index: IMEMR Main subject: Tumor Necrosis Factor-alpha / Antibodies, Monoclonal, Humanized Limits: Humans Language: Fr Journal: Tunisie Med. Year: 2012